These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6820897)

  • 1. [Bladder cancer: chemotherapy of advanced bladder cancer].
    Koiso K
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):377-86. PubMed ID: 6820897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemotherapy of advanced bladder carcinoma.
    deKernion JB
    Cancer Res; 1977 Aug; 37(8 Pt 2):2771-4. PubMed ID: 326391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic therapy of bladder cancer.
    Salem PA
    Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristic and effective usage of adriamycin].
    Horiuchi K; Akimoto M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs.
    Wang D; Wang Z; Tian B; Li X; Li S; Tian Y
    Int J Urol; 2008 May; 15(5):435-41. PubMed ID: 18452462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma].
    Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
    Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy in the multi-disciplinary treatment of head and neck tumors: evaluation of a chemosensitivity test].
    Saito H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1744-52. PubMed ID: 3729480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
    J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
    Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L
    BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
    Lehmann J; Retz M; Stöckle M
    World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder].
    Li Q; Xu X; Liu J
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):308-9. PubMed ID: 10920993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].
    Liberti M; Tenaglia R; De Berardinis E; Gentile V
    Minerva Med; 1984 Feb; 75(8):391-4. PubMed ID: 6424059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of bladder tumors].
    Vallet D; Cappelaere P; Adenis L; Demaille A
    Lille Med; 1978; 23(7):486-9. PubMed ID: 364222
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
    Soloway MS; Cox CE
    Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
    Anton-Aparicio LM; Urmeneta J; Borras M; Balaguer R; Berián JM
    Actas Urol Esp; 1985; 9(6):517-22. PubMed ID: 3938597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.